Company Overview
- Headquarters
- 245 First Street Suite 1400, Cambridge MA
- Website
- akebia.com
- mn****@akebia.com
- Phone
- (617) 871-2098
- Employees
- 321
- Founded in
- 2007
- Industry
- BioTech/Drugs
- Stock Symbol
- NASDAQ:AKB
- NAICS Code
-
NAICS Code 54171 CompaniesNAICS Code 541714 CompaniesNAICS Code 32 CompaniesNAICS Code 541 CompaniesNAICS Code 54 CompaniesNAICS Code 3254 CompaniesNAICS Code 325 CompaniesNAICS Code 5417 Companies
- SIC Code
-
SIC Code 87 CompaniesSIC Code 28 CompaniesSIC Code 873 CompaniesSIC Code 283 Companies
Financials & Stats
Revenue
$223B
Total Funding Amount
$100M
Who is Akebia Therapeutics Inc
Akebia Therapeutics Inc. is a biopharmaceutical company headquartered in Cambridge, Massachusetts. The company employs 321 people and generated $223 million in revenue. Akebia Therapeutics focuses on developing and commercializing treatments for individuals living with kidney disease. Akebia Therapeutics is committed to improving the lives of people affected by kidney disease through the advancement of innovative therapies. For more information about Akebia Therapeutics and its work, please visit akebia.com/.
Company Leadership
Akebia Therapeutics Inc Industry Tags
Akebia Therapeutics Inc Tech Stack
Companies Similar to Akebia Therapeutics Inc
Analyze industry trends and opportunities by examining competitors and companies comparable to Akebia Therapeutics Inc, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 223M | 1,032 | Emeryville, CA | 2003 | |
| 209M | 164 | Cranbury, NJ | 2007 | |
| 178M | 1,374 | Menlo Park, CA | 2016 | |
| 167M | 667 | Philadelphia, PA | 1996 | |
| 140M | 330 | La Vista, NE | 1971 |